Sun Pharma launches CEQUA for Treatment of Dry Eye Disease in US
Pharma Major, Sun Pharmaceutical Industries Ltd on Monday announced that one of its wholly-owned subsidiaries has commercialised CEQUA (Cyclosporine Ophthalmic Solution) 0.09 per cent in the US. CEQUA, which offers …
Sun Pharma launches CEQUA for Treatment of Dry Eye Disease in US Read More